The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Cancer
Glavni autori: Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2018
Teme:
Corrigendum
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5785753/
https://ncbi.nlm.nih.gov/pubmed/29315294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.418
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items